V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210035917 | 210030719 | 1.75 | 76.2 | Disease modification (D) | 2015-04-12 | 2015-05-11 | Temozolomide + RT | null | null | 210017673 | TEMOZOLOMIDE + RT |
| 210035918 | 210009133 | 1.78 | 72.4 | Adjuvant (A) | 2018-01-14 | 2018-01-29 | IBRUTINIB | N | N | 210017747 | IBRUTINIB |
| 210035919 | 210009137 | 1.57 | 85.3 | Adjuvant (A) | 2018-06-15 | 2018-06-16 | Rituximab | N | N | 210017755 | RITUXIMAB |
| 210035921 | 210009158 | 1.46 | 45.6 | Palliative (P) | 2012-12-21 | 2013-05-14 | IBRUTINIB | N | N | 210017842 | IBRUTINIB |
| 210035922 | 210019804 | 1.6 | 65 | Adjuvant (A) | 2014-11-13 | 2015-11-17 | IBRUTINIB | N | N | 210017908 | IBRUTINIB |
| 210035923 | 210019814 | 1.62 | 98.7 | Not known (9) | 2018-10-23 | 2018-10-25 | Lomustine | N | N | 210017973 | LOMUSTINE |
| 210035924 | 210009193 | null | 63 | Palliative (P) | null | 2016-09-24 | Lomustine | 2 | null | 210017976 | LOMUSTINE |
| 210035925 | 210019825 | 1.81 | 0 | Palliative (P) | 2018-04-16 | 2018-04-16 | Lomustine | N | N | 210018027 | LOMUSTINE |
| 210035926 | 210009209 | 1.82 | 106 | Palliative (P) | 2017-03-09 | 2017-03-09 | Rituximab | N | N | 210018045 | RITUXIMAB |
| 210035927 | 210030762 | 1.64 | 56.8 | Disease modification (D) | null | 2017-03-15 | IBRUTINIB | N | N | 210018065 | IBRUTINIB |
| 210035928 | 210009225 | 1.8 | 66 | Disease modification (D) | 2018-06-26 | 2018-06-26 | Rituximab | 2 | N | 210018080 | RITUXIMAB |
| 210035929 | 210009232 | null | 96.2 | Adjuvant (A) | 2015-06-04 | 2016-07-08 | IBRUTINIB | 02 | N | 210018105 | IBRUTINIB |
| 210035930 | 210019858 | 1.64 | 56 | Disease modification (D) | 2019-06-16 | 2019-06-16 | Lomustine | null | null | 210018165 | LOMUSTINE |
| 210035931 | 210026698 | 1.51 | 92 | Palliative (P) | 2018-01-11 | 2018-01-11 | Rituximab | 02 | N | 210018210 | RITUXIMAB |
| 210035932 | 210009256 | null | 71.7 | null | 2015-12-16 | 2015-12-22 | Lomustine | N | N | 210018213 | LOMUSTINE |
| 210035934 | 210009262 | 1.57 | 74.95 | Disease modification (D) | 2016-06-12 | 2017-02-23 | Rituximab | N | N | 210018227 | RITUXIMAB |
| 210035935 | 210026705 | 1.64 | 80 | Disease modification (D) | 2016-04-11 | 2016-09-09 | Lomustine | N | N | 210018243 | LOMUSTINE |
| 210035936 | 210009274 | 1.83 | 65.3 | Palliative (P) | 2015-12-20 | 2015-12-27 | Lomustine | Y | N | 210018264 | LOMUSTINE |
| 210035937 | 210019876 | 1.63 | 77.9 | Palliative (P) | 2014-12-27 | 2015-02-19 | IBRUTINIB | 2 | N | 210018266 | IBRUTINIB |
| 210035938 | 210009280 | 1.6 | 69.3 | Disease modification (D) | 2015-09-06 | 2015-09-06 | IBRUTINIB | N | N | 210018276 | IBRUTINIB |
| 210035939 | 210009282 | 1.91 | 109 | null | 2016-08-28 | 2016-08-30 | Lomustine | 02 | N | 210018278 | LOMUSTINE |
| 210035940 | 210009289 | 1.47 | 59.4 | Curative (C) | 2017-11-22 | 2018-08-11 | Lomustine | N | N | 210018288 | LOMUSTINE |
| 210035942 | 210009298 | null | 98.2 | Palliative (P) | 2018-05-02 | 2018-05-03 | Lomustine | N | N | 210018321 | LOMUSTINE |
| 210035943 | 210019893 | 1.6 | 70 | Palliative (P) | 2018-04-10 | 2018-03-13 | Rituximab | 02 | N | 210018334 | RITUXIMAB |
| 210035944 | 210030796 | 1.8 | 88.4 | Palliative (P) | 2013-10-23 | 2013-10-24 | Lomustine | N | N | 210018336 | LOMUSTINE |
| 210035945 | 210037405 | 1.76 | 0 | Disease modification (D) | 2012-05-18 | 2014-09-06 | Rituximab | 02 | N | 210018349 | RITUXIMAB |
| 210035946 | 210009314 | 1.82 | 63.5 | null | 2013-10-16 | 2013-10-16 | Rituximab | N | N | 210018353 | RITUXIMAB |
| 210035947 | 210009318 | 1.68 | 76 | Palliative (P) | 2016-10-10 | 2016-12-12 | Lomustine | 2 | N | 210018363 | LOMUSTINE |
| 210035948 | 210009326 | null | 0 | Palliative (P) | 2018-06-03 | 2018-06-05 | Rituximab | 1 | N | 210018380 | RITUXIMAB |
| 210035949 | 210009328 | 1.64 | 85.5 | Disease modification (D) | 2018-06-16 | 2018-12-27 | IBRUTINIB | 02 | N | 210018384 | IBRUTINIB |
| 210035950 | 210009338 | 1.29 | 51 | Curative (C) | null | 2014-01-31 | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | null | null | 210018415 | FCR |
| 210035951 | 210009340 | null | 74.9 | Curative (C) | 2014-06-17 | 2014-06-17 | Bendamustine+Rituximab(Sub Courses) | N | null | 210018417 | BENDAMUSTINE + RITUXIMAB |
| 210035952 | 210009343 | 1.5 | 20 | Curative (C) | 2013-11-08 | 2014-10-02 | FCR Oral - Cycle 1 | Y | N | 210018435 | FCR |
| 210035953 | 210009352 | null | null | Curative (C) | 2015-06-23 | 2015-07-02 | BENDAMUSTINE + RITUXIMAB | N | N | 210018451 | BENDAMUSTINE + RITUXIMAB |
| 210035954 | 210019928 | 1.77 | 78.7 | Adjuvant (A) | 2015-02-21 | 2015-04-21 | FLAIR Trial | Y | N | 210018466 | FLAIR TRIAL |
| 210035955 | 210019932 | null | 89.6 | Curative (C) | 2017-04-10 | 2017-12-08 | VINCRISTINE | Y | null | 210018484 | VINCRISTINE |
| 210035957 | 210009376 | 1.66 | 85.4 | Palliative (P) | 2017-12-25 | 2018-01-25 | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | 2 | N | 210018518 | FCR |
| 210035958 | 210019945 | null | null | Curative (C) | 2018-02-08 | 2018-06-01 | FLAIR Trial | Y | N | 210018537 | FLAIR TRIAL |
| 210035959 | 210034916 | 1.73 | 90 | Curative (C) | 2013-10-13 | 2013-12-18 | Bendamustine+Rituximab (1st Course) | null | N | 210018539 | BENDAMUSTINE + RITUXIMAB |
| 210035960 | 210009385 | 1.29 | 69.3 | Palliative (P) | 2017-08-01 | 2017-11-27 | FLAIR Trial | 1 | N | 210018557 | FLAIR TRIAL |
| 210035961 | 210009390 | 1.73 | null | Curative (C) | 2013-09-23 | 2013-11-05 | FCR Oral - Cycle 2 onwards | 2 | N | 210018567 | FCR |
| 210035962 | 210026766 | 1.6 | 60.3 | Curative (C) | 2015-12-31 | 2016-11-18 | FCR Oral - Cycle 2 onwards | 02 | N | 210018577 | FCR |
| 210035963 | 210009395 | 1.7 | 46 | Curative (C) | 2017-01-02 | 2017-02-20 | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | N | N | 210018579 | FCR |
| 210035964 | 210009400 | 1.86 | 69 | Curative (C) | 2016-09-10 | 2016-10-09 | Bendamustine+Rituximab(Sub Courses) | N | N | 210018581 | BENDAMUSTINE + RITUXIMAB |
| 210035965 | 210009402 | 1.77 | 57.8 | Curative (C) | 2015-05-17 | 2015-06-15 | BENDAMUSTINE + RITUXIMAB | N | N | 210018591 | BENDAMUSTINE + RITUXIMAB |
| 210035966 | 210019963 | null | null | Curative (C) | 2015-01-27 | 2015-02-08 | FLAIR Trial | N | null | 210018597 | FLAIR TRIAL |
| 210035967 | 210030818 | 1.7 | null | Curative (C) | 2014-06-13 | 2014-06-13 | FLAIR Trial | Y | N | 210018608 | FLAIR TRIAL |
| 210035968 | 210009413 | 1.53 | 63 | Palliative (P) | 2017-05-19 | 2017-08-22 | VINCRISTINE | N | N | 210018641 | VINCRISTINE |
| 210035969 | 210009415 | 1.65 | 25.1 | Curative (C) | 2015-11-11 | 2016-10-15 | BENDAMUSTINE + RITUXIMAB | N | N | 210018654 | BENDAMUSTINE + RITUXIMAB |
| 210035970 | 210009423 | 1.76 | 18.1 | Curative (C) | null | 2019-02-05 | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | 02 | null | 210018684 | FCR |